196 related articles for article (PubMed ID: 25324198)
21. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
[TBL] [Abstract][Full Text] [Related]
22. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
23. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
Peterse EFP; Meester RGS; de Jonge L; Omidvari AH; Alarid-Escudero F; Knudsen AB; Zauber AG; Lansdorp-Vogelaar I
J Natl Cancer Inst; 2021 Feb; 113(2):154-161. PubMed ID: 32761199
[TBL] [Abstract][Full Text] [Related]
24. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.
van Hees F; Habbema JD; Meester RG; Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG
Ann Intern Med; 2014 Jun; 160(11):750-9. PubMed ID: 24887616
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
[TBL] [Abstract][Full Text] [Related]
26. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM
JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.
Aronsson M; Carlsson P; Levin LÅ; Hager J; Hultcrantz R
Br J Surg; 2017 Jul; 104(8):1078-1086. PubMed ID: 28561259
[TBL] [Abstract][Full Text] [Related]
28. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
van Hees F; Saini SD; Lansdorp-Vogelaar I; Vijan S; Meester RG; de Koning HJ; Zauber AG; van Ballegooijen M
Gastroenterology; 2015 Nov; 149(6):1425-37. PubMed ID: 26253304
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness of Community Interventions for Colorectal Cancer Screening: Low-Income Hispanic Population.
Lairson DR; Kim J; Byrd T; Salaiz R; Shokar NK
Health Promot Pract; 2018 Nov; 19(6):863-872. PubMed ID: 29290126
[TBL] [Abstract][Full Text] [Related]
31. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
32. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of screening strategies for colorectal cancer.
Barzi A; Lenz HJ; Quinn DI; Sadeghi S
Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
[TBL] [Abstract][Full Text] [Related]
34. Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think.
Luque JS; Wallace K; Blankenship BF; Roos LG; Berger FG; LaPelle NR; Melvin CL
J Community Health; 2018 Dec; 43(6):1085-1092. PubMed ID: 29767821
[TBL] [Abstract][Full Text] [Related]
35. Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.
Dinh TA; Alperin P; Walter LC; Smith R
J Gen Intern Med; 2012 Jun; 27(6):730-8. PubMed ID: 22237663
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.
Rice K; Sharma K; Li C; Butterly L; Gersten J; DeGroff A
Cancer; 2019 Feb; 125(4):601-609. PubMed ID: 30548480
[TBL] [Abstract][Full Text] [Related]
38. Pioneering Annual Colorectal Cancer Screening and Treatment Targeting Low Income Communities in Malaysia (20102015).
Tze CN; Fitzgerald H; Qureshi A; Tan HJ; Low ML
Asian Pac J Cancer Prev; 2016; 17(7):3179-83. PubMed ID: 27509948
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
40. Should colorectal cancer screening start at different ages for men and women? Cost-effectiveness analysis for a resource-constrained service.
Thomas C; Mandrik O; Whyte S; Saunders CL; Griffin SJ; Usher-Smith JA
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1344. PubMed ID: 33533190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
